#DiabetesCare #Pharma #Pharmacology #DiabetesAwareness #Gliptins #MechanismOfAction #Onpharma Onpharma Tales Post Understanding Diabetes Treatment: Mechanism of Action of Gliptins (DPP-4 Inhibitors) Gliptins (Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin) are a widely used class of oral antidiabetic drugs
GLP-1 receptor agonists produce substantial and sustained reductions in food intake clinical trials show average body weight reductions of 1322% depending on the drug, driven by smaller portions, reduced appetite for high-fat and ultra-processed foods, and a shift toward more frequent but smaller eating occasions
It was also found to be active in burn models
Full Name : Darragh OCarroll MD Professional Title(s) : Board Certified Emergency Physician Current Role at Hims & Hers : Medical Advisor Education : Bachelor of Science in Human Physiology - Boston University, 2007 Medical Doctorate - University of Hawaii John A
P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage